Monkeypox VaccineThe vaccine most commonly used for preventing monkeypox infection is JYNNEOS (also known as Imvamune or Imvanex) which has been licensed by the U.S. Food and Drug Administration (FDA).
|
|
About the JYNNEOS vaccineWhen properly administered before or soon after exposure, vaccines can help protect against monkeypox illness.
On August 9, CDC and FDA released an EUA (Emergency Use Authorization) allowing an alternative dose vaccination regimen in people 18 years and over and allowing the use of the JYNNEOS vaccine in individuals younger than 18 years. |
ATTENTION:
We currently do not have access to the monkeypox vaccine and include a link to the MA DPH that has information about vaccine access. Click here for more information: https://www.mass.gov/info-details/monkeypox-vaccination
We currently do not have access to the monkeypox vaccine and include a link to the MA DPH that has information about vaccine access. Click here for more information: https://www.mass.gov/info-details/monkeypox-vaccination
Monkeypox Information Resources
- About Monkeypox | CDC
- The 2022 Monkeypox Outbreak| CDC
- Monkeypox Overview | MA Department of Public Health
- Monkeypox Vaccination | MA Department of Public Health
- Monkeypox FAQs | NH Department of Health & Human Services
